Clinical Research Directory
Browse clinical research sites, groups, and studies.
Mycophenolate After Stem Cell Transplant for Systemic Sclerosis
Sponsor: Ottawa Hospital Research Institute
Summary
A pilot single center randomized trial to test whether a full-scale RCT evaluating the role of post-AHSCT maintenance immunosuppression with MMF in preventing disease relapse is feasible . We are studying whether a brief course of treatment with MMF after AHSCT will serve to prevent disease relapse.
Official title: Immunomodulatory Maintenance Therapy Post-Autologous Hematopoietic Stem Cell Transplantation for Prevention of Systemic Sclerosis Relapse: A Pilot Randomized Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
6
Start Date
2026-12
Completion Date
2029-12
Last Updated
2026-10-19
Healthy Volunteers
No
Conditions
Interventions
Mycophenolate Mofetil 1000 mg twice daily
MMF 1000mg p.o. b.i.d. starting at day 90 post-AHSCT and continued for 6 months.
Locations (1)
The Ottawa Hospital
Ottawa, Ontario, Canada